Diamagnetic chemical exchange saturation transfer (diaCEST) liposomes: Physicochemical properties and imaging applications

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 6, Issue 1, 2014, Pages 111-124

  Chan, Kannie W Y ^a,b   Bulte, Jeff W M ^a,b   Mcmahon, Michael T ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIODEGRADABLE COMPOUNDS; BIOMEDICAL APPLICATIONS; CHEMICAL EXCHANGE SATURATION TRANSFER; CONTROLLED RELEASE; IMAGING APPLICATIONS; MICROMOLAR CONCENTRATION; MRI CONTRAST AGENTS; PHYSICOCHEMICAL PROPERTY;

CHEMICAL DETECTION; CHEMOTHERAPY; DISEASES; MAGNETIC RESONANCE IMAGING; MEDICAL APPLICATIONS;

LIPOSOMES;

CONTRAST MEDIUM; DOXORUBICIN; FLUORINE; GADOLINIUM; GLYCOSAMINOGLYCAN; IRON OXIDE; LANTHANIDE; LIPOSOME; MACROGOL; NANOCARRIER; POLYARGININE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CELL THERAPY; CELL TRANSPLANTATION; CHRONIC PANCREATITIS; DIABETES MELLITUS; DIAMAGNETIC CHEMICAL EXCHANGE SATURATION TRANSFER; HEART DISEASE; HUMAN; IN VIVO STUDY; LIPOSOMAL DELIVERY; LIVER FAILURE; LYMPHATIC DRAINAGE; NEOPLASM; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOSPHOLIPID BILAYER; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; TUMOR MICROENVIRONMENT;

ANIMALS; CELL- AND TISSUE-BASED THERAPY; CONTRAST MEDIA; LIPOSOMES; MAGNETIC RESONANCE IMAGING; MICE; MOLECULAR IMAGING; NANOMEDICINE;

EID: 84890234523     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1246     Document Type: Article

References (108)

1. van Zijl PC, Yadav NN. Chemical exchange saturation transfer (CEST): what is in a name and what isn't? Magn Reson Med 2011, 65:927-948.
2. Sherry AD, Woods M. Chemical exchange saturation transfer contrast agents for magnetic resonance imaging. Ann Rev Biomed Eng 2008, 10:391-411.
3. Aime S, Castelli DD, Crich SG, Gianolio E, Terreno E. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications. Acc Chem Res 2009, 42:822-831.
4. McMahon MT, Gilad AA, DeLiso MA, Berman SM, Bulte JW, van Zijl PC. New 'multicolor' polypeptide diamagnetic chemical exchange saturation transfer (DIACEST) contrast agents for MRI. Magn Reson Med 2008, 60:803-812.
5. Forsén S, Hoffman RA. Study of moderately rapid chemical exchange reactions by means of nuclear magnetic double resonance. J Chem Phys 1963, 39:2892.
6. Ward KM, Aletras AH, Balaban RS. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson 2000, 143:79-87.
7. Huang CH, Hammell J, Ratnakar SJ, Sherry AD, Morrow JR. Activation of a PARACEST agent for MRI through selective outersphere interactions with phosphate diesters. Inorg Chem 2010, 49:5963-5970.
8. Bar-Shir A, Gilad AA, Chan KWY, Liu G, van Zijl PCM, Bulte JWM, McMahon MT. Metal ion sensing using ion chemical exchange saturation transfer 19F magnetic resonance imaging. J Am Chem Soc 2013. 135:12164-12167.
9. Woods M, Woessner DE, Sherry AD. Paramagnetic lanthanide complexes as PARACEST agents for medical imaging. Chem Soc Rev 2006, 35:500-511.
10. Aime S, Barge A, Delli Castelli D, Fedeli F, Mortillaro A, Nielsen FU, Terreno E. Paramagnetic Lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications. Magn Reson Med 2002, 47:639-648.
11. Goffeney N, Bulte JW, Duyn J, Bryant LH Jr, van Zijl PC. Sensitive NMR detection of cationic-polymer-based gene delivery systems using saturation transfer via proton exchange. J Am Chem Soc 2001, 123:8628-8629.
12. Schroder L, Lowery TJ, Hilty C, Wemmer DE, Pines A. Molecular imaging using a targeted magnetic resonance hyperpolarized biosensor. Science 2006, 314:446-449.
13. Dorazio SJ, Tsitovich PB, Siters KE, Spernyak JA, Morrow JR. Iron(II) PARACEST MRI contrast agents. J Am Chem Soc 2011, 133:14154-14156.
14. Ward KM, Balaban RS. Determination of pH using water protons and chemical exchange dependent saturation transfer (CEST). Magn Reson Med 2000, 44:799-802.
15. Wen Z, Hu S, Huang F, Wang X, Guo L, Quan X, Wang S, Zhou J. MR imaging of high-grade brain tumors using endogenous protein and peptide-based contrast. NeuroImage 2010, 51:616-622.
16. Zhou J, Tryggestad E, Wen Z, Lal B, Zhou T, Grossman R, Wang S, Yan K, Fu DX, Ford E, et al. Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med 2011, 17:130-134.
17. Keupp J, Baltes C, Harvey PR, van den Brink J. Parallel RF transmission based MRI technique for highly sensitive detection of amide proton transfer in the human brain. Proceedings of the International Society for Magnetic Resonance in Medicine 2011.
18. Lammers T, Aime S, Hennink WE, Storm G, Kiessling F. Theranostic nanomedicine. Acc Chem Res 2011, 44:1029-1038.
19. Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 2013, 65:36-48.
20. Aime S, Delli Castelli D, Terreno E. Highly sensitive MRI chemical exchange saturation transfer agents using liposomes. Angew Chem Int Ed 2005, 117:5649-5651.
21. Winter PM. Magnetic resonance chemical exchange saturation transfer imaging and nanotechnology. WIREs Nanomed Nanobiotechnol 2012, 4:389-398.
22. Liu G, Moake M, Har-el YE, Long CM, Chan KW, Cardona A, Jamil M, Walczak P, Gilad AA, Sgouros G, et al. In vivo multicolor molecular MR imaging using diamagnetic chemical exchange saturation transfer liposomes. Magn Reson Med 2012, 67:1106-1113.
23. Terreno E, Cabella C, Carrera C, Delli Castelli D, Mazzon R, Rollet S, Stancanello J, Visigalli M, Aime S. From spherical to osmotically shrunken paramagnetic liposomes: an improved generation of LIPOCEST MRI agents with highly shifted water protons. Angew Chem Int Ed 2007, 46:966-968.
24. Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965, 13:238-252.
25. Gregoriadis G. The carrier potential of liposomes in biology and medicine (first of two parts). New Engl J Med 1976, 295:704-710.
26. Zhao JM, Har-el YE, McMahon MT, Zhou J, Sherry AD, Sgouros G, Bulte JW, van Zijl PC. Size-induced enhancement of chemical exchange saturation transfer (CEST) contrast in liposomes. J Am Chem Soc 2008, 130:5178-5184.
27. Terreno E, Sanino A, Carrera C, Castelli DD, Giovenzana GB, Lombardi A, Mazzon R, Milone L, Visigalli M, Aime S. Determination of water permeability of paramagnetic liposomes of interest in MRI field. J Inorg Biochem 2008, 102:1112-1119.
28. Szoka F, Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci U S A 1978, 75:4194-4198.
29. Olson F, Hunt CA, Szoka FC, Vail WJ, Papahadjopoulos D. Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim Biophys Acta 1979, 557:9-23.
30. Chang HI, Yeh MK. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int J Nanomed 2012, 7:49-60.
31. Storm G, Roerdink FH, Steerenberg PA, Dejong WH, Crommelin DJA. Influence of lipid-composition on the antitumor-activity exerted by doxorubicin-containing liposomes in a rat solid tumor-model. Cancer Res 1987, 47:3366-3372.
32. Cullis PR. Lateral diffusion rates of phosphatidylcholine in vesicle membranes - effects of cholesterol and hydrocarbon phase-transitions. FEBS Lett 1976, 70:223-228.
33. Bibi S, Lattmann E, Mohammed AR, Perrie Y. Trigger release liposome systems: local and remote controlled delivery? J Microencapsul 2012, 29:262-276.
34. Allen TM, Hansen C. Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim Biophys Acta 1991, 1068:133-141.
35. Klibanov AL, Maruyama K, Torchilin VP, Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 1990, 268:235-237.
36. Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomed 2006, 1:297-315.
37. Barenholz Y. Doxil(R)--the first FDA-approved nano-drug: lessons learned. J Control Release 2012, 160:117-134.
38. Bulte JWM, de Cuyper M, Despres D, Frank JA. Short- vs. long-circulating magnetoliposomes as bone marrow-seeking MR contrast agents. J Magn Reson Imaging 1999, 9:329-335.
39. Strijkers GJ, Mulder WJ, van Heeswijk RB, Frederik PM, Bomans P, Magusin PC, Nicolay K. Relaxivity of liposomal paramagnetic MRI contrast agents. Magma 2005, 18:186-192.
40. Biswas S, Dodwadkar NS, Deshpande PP, Parab S, Torchilin VP. Surface functionalization of doxorubicin-loaded liposomes with octa-arginine for enhanced anticancer activity. Eur J Pharma Biopharma 2013. 84:517-525.
41. Torchilin VP, Klibanov AL, Huang L, O'Donnell S, Nossiff ND, Khaw BA. Targeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium. FASEB J 1992, 6:2716-2719.
42. Dreher MR, Liu W, Michelich CR, Dewhirst MW, Yuan F, Chilkoti A. Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. J Natl Cancer Inst 2006, 98:335-344.
43. van Bochove GS, Paulis LE, Segers D, Mulder WJ, Krams R, Nicolay K, Strijkers GJ. Contrast enhancement by differently sized paramagnetic MRI contrast agents in mice with two phenotypes of atherosclerotic plaque. Contrast Media Mol Imaging 2011, 6:35-45.
44. Mulder WJ, Strijkers GJ, Griffioen AW, van Bloois L, Molema G, Storm G, Koning GA, Nicolay K. A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. Bioconjug Chem 2004, 15:799-806.
45. Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednarski MD, Li KCP. Detection of tumor angiogenesis in vivo by α(v)β(3)-targeted magnetic resonance imaging. Nat Med 1998, 4:623-626.
46. Juweid M, Neumann R, Paik C, Perezbacete MJ, Sato J, Vanosdol W, Weinstein JN. Micropharmacology of monoclonal-antibodies in solid tumors-direct experimental-evidence for a binding-site barrier. Cancer Res 1992, 52:5144-5153.
47. Cheng Z, Al Zaki A, Hui JZ, Muzykantov VR, Tsourkas A. Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science 2012, 338:903-910.
48. Kok MB, Hak S, Mulder WJ, van der Schaft DW, Strijkers GJ, Nicolay K. Cellular compartmentalization of internalized paramagnetic liposomes strongly influences both T1 and T2 relaxivity. Magn Reson Med 2009, 61:1022-1032.
49. Delli Castelli D, Dastru W, Terreno E, Cittadino E, Mainini F, Torres E, Spadaro M, Aime S. In vivo MRI multicontrast kinetic analysis of the uptake and intracellular trafficking of paramagnetically labeled liposomes. J Control Release 2010, 144:271-279.
50. Hossann M, Wang T, Syunyaeva Z, Wiggenhorn M, Zengerle A, Issels RD, Reiser M, Lindner LH, Peller M. Non-ionic Gd-based MRI contrast agents are optimal for encapsulation into phosphatidyldiglycerol-based thermosensitive liposomes. J Control Release 2013, 166:22-29.
51. Lasic DD. Liposomes in Gene Delivery. CRC Press LLC, USA; 1997.
52. Hwang K, Merriam J, Beaumier P, Luk K. Encapsulation, with high efficiency, of radioactive metal ions in liposomes. Biochim Biophys Acta 1982, 716:101-109.
53. Aime S, Delli Castelli D, Lawson D, Terreno E. Gd-loaded liposomes as T1, susceptibility, and CEST agents, all in one. J Am Chem Soc 2007, 129:2430-2431.
54. Mulder WJ, Strijkers GJ, van Tilborg GA, Griffioen AW, Nicolay K. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed 2006, 19:142-164.
55. Caravan P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem Soc Rev 2006, 35:512-523.
56. Langereis S, Geelen T, Grüll H, Strijkers GJ, Nicolay K. Paramagnetic liposomes for molecular MRI and MRI-guided drug delivery. NMR Biomed 2013. 26:728-744.
57. Bulte JW. In vivo MRI cell tracking: clinical studies. Am J Roentgenol 2009, 193:314-325.
58. Tassa C, Shaw SY, Weissleder R. Dextran-coated iron oxide nanoparticles a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. Acc Chem Res 2011, 44:842-852.
59. Decuyper M, Joniau M. Magnetoliposomes-formation and structural characterization. Eur Biophys J Biophys Lett 1988, 15:311-319.
60. Bulte JW, Ma LD, Magin RL, Kamman RL, Hulstaert CE, Go KG, The TH, de Leij L. Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran-magnetite particles. Magn Reson Med 1993, 29:32-37.
61. Soenen SJ, Vande Velde G, Ketkar-Atre A, Himmelreich U, De Cuyper M. Magnetoliposomes as magnetic resonance imaging contrast agents. WIREs Nanomed Nanobiotechnol 2011, 3:197-211.
62. Terreno E, Delli Castelli D, Violante E, Sanders HM, Sommerdijk NA, Aime S. Osmotically shrunken LIPOCEST agents: an innovative class of magnetic resonance imaging contrast media based on chemical exchange saturation transfer. Chemistry 2009, 15:1440-1448.
63. Opina AC, Ghaghada KB, Zhao P, Kiefer G, Annapragada A, Sherry AD. TmDOTA-tetraglycinate encapsulated liposomes as pH-sensitive LipoCEST agents. PloS One 2011, 6:e27370.
64. Torres E, Mainini F, Napolitano R, Fedeli F, Cavalli R, Aime S, Terreno E. Improved paramagnetic liposomes for MRI visualization of pH triggered release. J Control Release 2011, 154:196-202.
65. Li AX, Wojciechowski F, Suchy M, Jones CK, Hudson RHE, Merton RS, Bartha R. A sensitive PARACEST contrast agent for temperature MRI: EU3+-DOTAM-Glycine (Gly)-Phenylalanine (Phe). Magn Reson Med 2008, 59:374-381.
66. Yoo B, Pagel MD. A PARACEST MRI contrast agent to detect enzyme activity. J Am Chem Soc 2006, 128:14032-14033.
67. Chauvin T, Durand P, Bernier M, Meudal H, Doan B-T, Noury F, Badet B, Beloeil J-C, Tóth É. Detection of enzymatic activity by PARACEST MRI: a general approach to target a large variety of enzymes. Angew Chem Int Ed 2008, 47:4370-4372.
68. Liu G, Song X, Chan KW, McMahon MT. Nuts and bolts of chemical exchange saturation transfer MRI. NMR Biomed 2013. 26:810-828.
69. Zhou J, Wilson DA, Sun PZ, Klaus JA, Van Zijl PC. Quantitative description of proton exchange processes between water and endogenous and exogenous agents for WEX, CEST, and APT experiments. Magn Reson Med 2004, 51:945-952.
70. Zaiss M, Schmitt B, Bachert P. Quantitative separation of CEST effect from magnetization transfer and spillover effects by Lorentzian-line-fit analysis of z-spectra. J Magn Reson 2011, 211:149-155.
71. Zaiss M, Schnurr M, Bachert P. Analytical solution for the depolarization of hyperpolarized nuclei by chemical exchange saturation transfer between free and encapsulated xenon (HyperCEST). J Chem Phys 2012, 136:144106.
72. Lee JS, Regatte RR, Jerschow A. Isolating chemical exchange saturation transfer contrast from magnetization transfer asymmetry under two-frequency rf irradiation. J Magn Reson 2012, 215:56-63.
73. Zu Z, Janve VA, Xu J, Does MD, Gore JC, Gochberg DF. A new method for detecting exchanging amide protons using chemical exchange rotation transfer. Magn Reson Med 2013, 69:637-647.
74. Jones CK, Polders D, Hua J, Zhu H, Hoogduin HJ, Zhou J, Luijten P, van Zijl PC. In vivo three-dimensional whole-brain pulsed steady-state chemical exchange saturation transfer at 7 T. Magn Reson Med 2012, 67:1579-1589.
75. Scheidegger R, Vinogradov E, Alsop DC. Amide proton transfer imaging with improved robustness to magnetic field inhomogeneity and magnetization transfer asymmetry using saturation with frequency alternating RF irradiation. Magn Reson Med 2011, 66:1275-1285.
76. van Zijl PC, Jones CK, Ren J, Malloy CR, Sherry AD. MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST). Proc Natl Acad Sci U S A 2007, 104:4359-4364.
77. Chan KW, McMahon MT, Kato Y, Liu G, Bulte JW, Bhujwalla ZM, Artemov D, van Zijl PC. Natural D-glucose as a biodegradable MRI contrast agent for detecting cancer. Magn Reson Med 2012, 68:1764-1773.
78. Nasrallah FA, Pages G, Kuchel PW, Golay X, Chuang KH. Imaging brain deoxyglucose uptake and metabolism by glucoCEST MRI. J Cerebral Blood Flow Metabol 2013. 33:1270-1278.
79. Kogan F, Singh A, Debrosse C, Haris M, Cai K, Nanga RP, Elliott M, Hariharan H, Reddy R. Imaging of glutamate in the spinal cord using GluCEST. NeuroImage 2013, 77:262-267.
80. Cai K, Haris M, Singh A, Kogan F, Greenberg JH, Hariharan H, Detre JA, Reddy R. Magnetic resonance imaging of glutamate. Nat Med 2012, 18:302-306.
81. Kogan F, Haris M, Singh A, Cai K, Debrosse C, Nanga RPR, Hariharan H, Reddy R. Method for high-resolution imaging of creatine in vivo using chemical exchange saturation transfer. Magn Reson Med 2013. doi:10.1002/mrm.24641.
82. Chan KW, Liu G, Song X, Kim H, Yu T, Arifin DR, Gilad AA, Hanes J, Walczak P, van Zijl PC, et al. MRI-detectable pH nanosensors incorporated into hydrogels for in vivo sensing of transplanted-cell viability. Nat Mater 2013, 12:268-275.
83. Zhou J, Lal B, Wilson DA, Laterra J, van Zijl PC. Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med 2003, 50:1120-1126.
84. Longo DL, Dastru W, Digilio G, Keupp J, Langereis S, Lanzardo S, Prestigio S, Steinbach O, Terreno E, Uggeri F, et al. Iopamidol as a responsive MRI-chemical exchange saturation transfer contrast agent for pH mapping of kidneys: In vivo studies in mice at 7 T. Magn Reson Med 2011, 65:202-211.
85. Snoussi K, Bulte JW, Gueron M, van Zijl PC. Sensitive CEST agents based on nucleic acid imino proton exchange: detection of poly(rU) and of a dendrimer-poly(rU) model for nucleic acid delivery and pharmacology. Magn Reson Med 2003, 49:998-1005.
86. McMahon MT, Gilad AA, Zhou J, Sun PZ, Bulte JW, van Zijl PC. Quantifying exchange rates in chemical exchange saturation transfer agents using the saturation time and saturation power dependencies of the magnetization transfer effect on the magnetic resonance imaging signal (QUEST and QUESP): Ph calibration for poly-L-lysine and a starburst dendrimer. Magn Reson Med 2006, 55:836-847.
87. Sun PZ. Simplified quantification of labile proton concentration-weighted chemical exchange rate (k(ws)) with RF saturation time dependent ratiometric analysis (QUESTRA): normalization of relaxation and rf irradiation spillover effects for improved quantitative chemical exchange saturation transfer (CEST) MRI. Magn Reson Med 2012, 67:936-942.
88. Dixon WT, Ren JM, Lubag AJM, Ratnakar J, Vinogradov E, Hancu I, Lenkinski RE, Sherry AD. A concentration-independent method to measure exchange rates in PARACEST agents. Magn Reson Med 2010, 63:625-632.
89. Song X, Gilad AA, Joel S, Liu G, Bar-Shir A, Liang Y, Gorelik M, Pekar JJ, van Zijl PC, Bulte JW, et al. CEST phase mapping using a length and offset varied saturation (LOVARS) scheme. Magn Reson Med 2012. 68:1074-1086.
90. Saar G, Zhang B, Ling W, Regatte RR, Navon G, Jerschow A. Assessment of glycosaminoglycan concentration changes in the intervertebral disc via chemical exchange saturation transfer. NMR Biomed 2012, 25:255-261.
91. Liu G, Gilad AA, Bulte JW, van Zijl PC, McMahon MT. High-throughput screening of chemical exchange saturation transfer MR contrast agents. Contrast Media Mol Imaging 2010, 5:162-170.
92. Kim M, Gillen J, Landman BA, Zhou J, van Zijl PC. Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments. Magn Reson Med 2009, 61:1441-1450.
93. Stancanello J, Terreno E, Castelli DD, Cabella C, Uggeri F, Aime S. Development and validation of a smoothing-splines-based correction method for improving the analysis of CEST-MR images. Contrast Media Mol Imaging 2008, 3:136-149.
94. Liu G, Ali MM, Yoo B, Griswold MA, Tkach JA, Pagel MD. PARACEST MRI with improved temporal resolution. Magn Reson Med 2009, 61:399-408.
95. Liu G, Chan K, Song X, Zhang J, Gilad AA, Bulte JWM, van Zijl PCM, McMahon MT. NOrmalized MAgnetization Ratio (NOMAR) filtering for creation of tissue selective contrast maps. Magn Reson Med 2012.
96. Dopfert J, Witte, C., Kunth, M., Schroder, L. Sensitivity enhancement of (Hyper-)CEST imaging series by exploiting redundancies in the spectral domain. Contrast Media Mol Imaging 2013.
97. Terreno E, Castelli DD, Milone L, Rollet S, Stancanello J, Violante E, Aime S. First ex-vivo MRI co-localization of two LIPOCEST agents. Contrast Media Mol Imaging 2008, 3:38-43.
98. Heneweer C, Gendy SE, Penate-Medina O. Liposomes and inorganic nanoparticles for drug delivery and cancer imaging. Ther Deliv 2012, 3:645-656.
99. Flament J, Geffroy F, Medina C, Robic C, Mayer JF, Meriaux S, Valette J, Robert P, Port M, Le Bihan D, et al. In vivo CEST MR imaging of U87 mice brain tumor angiogenesis using targeted LipoCEST contrast agent at 7 T. Magn Reson Med 2013, 69:179-187.
100. Cormode DP, Briley-Saebo KC, Mulder WJ, Aguinaldo JG, Barazza A, Ma Y, Fisher EA, Fayad ZA. An ApoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection. Small 2008, 4:1437-1444.
101. Langereis S, Keupp J, van Velthoven JL, de Roos IH, Burdinski D, Pikkemaat JA, Grull H. A temperature-sensitive liposomal 1H CEST and 19F contrast agent for MR image-guided drug delivery. J Am Chem Soc 2009, 131:1380-1381.
102. Keupp J, Rahmer J, Grasslin I, Mazurkewitz PC, Schaeffter T, Lanza GM, Wickline SA, Caruthers SD. Simultaneous dual-nuclei imaging for motion corrected detection and quantification of 19F imaging agents. Magn Reson Med 2011, 66:1116-1122.
103. Hernández RM, Orive G, Murua A, Pedraz JL. Microcapsules and microcarriers for in situ cell delivery. Adv Drug Deliv Rev 2010, 62:711-730.
104. Paul A, Ge Y, Prakash S, Shum-Tim D. Microencapsulated stem cells for tissue repairing: implications in cell-based myocardial therapy. Regen Med 2009, 4:733-745.
105. Ahrens ET, Zhong J. In vivo MRI cell tracking using perfluorocarbon probes and fluorine-19 detection. NMR Biomed 2013, 26:860-871.
106. Kircher MF, Gambhir SS, Grimm J. Noninvasive cell-tracking methods. Nat Rev 2011, 8:677-688.
107. Arifin DR, Kedziorek DA, Fu Y, Chan KW, McMahon MT, Weiss CR, Kraitchman DL, Bulte JW. Microencapsulated cell tracking. NMR Biomed 2013, 26:850-859.
108. Guenoun J, Ruggiero A, Doeswijk G, Janssens RC, Koning GA, Kotek G, Krestin GP, Bernsen MR. In vivo quantitative assessment of cell viability of gadolinium or iron-labeled cells using MRI and bioluminescence imaging. Contr Med Mol Imag 2013, 8:165-174.